Literature DB >> 9134429

Increase of rat colon carcinoma cells tumorigenicity by alpha(1-2) fucosyltransferase gene transfection.

C Goupille1, F Hallouin, K Meflah, J Le Pendu.   

Abstract

Fucosylated histo-blood group antigens such as Lewis b, Lewis Y, and H accumulate in colon carcinoma and this is accompanied by a clear increase in alpha(1-2)fucosyltransferase activity, a key enzyme for the biosynthesis of these antigens. Yet the biological significance of alpha(1-2) fucosylated structures is not well defined. We have transfected a poorly tumorigenic rat colon carcinoma cell line with the human H blood group alpha(1-2)fucosyltransferase cDNA. This resulted in cell surface expression of H antigens with a concomitant decrease of sialic acid substituted and free beta-galactosides. Immunoprecipitation experiments showed that H antigens were essentially borne by variants of CD44 carrying amino acid sequences encoded by exon v6. The transfected cells showed increased motility in a wound healing assay, without changing their proliferation rates. Parental and control cells transfected with an empty vector formed small tumors that always regressed after 30 days when injected subcutaneously to syngeneic rats. In contrast, alpha(1-2)fucosyltransferase transfectants were able to form progressive tumors. Increased tumorigenicity was also visible in nude mice. These results demonstrate that alpha(1-2)fucosylated antigens contribute directly to aggressiveness of colon carcinoma cells. This could occur by altering a function of CD44 variants.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9134429     DOI: 10.1093/glycob/7.2.221

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  18 in total

1.  Deletion of A-antigen in a human cancer cell line is associated with reduced promoter activity of CBF/NF-Y binding region, and possibly with enhanced DNA methylation of A transferase promoter.

Authors:  S Iwamoto; D A Withers; K Handa; S Hakomori
Journal:  Glycoconj J       Date:  1999-10       Impact factor: 2.916

2.  Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases.

Authors:  T Petretti; W Kemmner; B Schulze; P M Schlag
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

3.  A rat experimental model for the design of vaccines against tumor associated antigens Tn and Sialyl-Tn.

Authors:  F Hallouin; C Goupille; J Rocher; J Le Pendu
Journal:  Glycoconj J       Date:  1999-11       Impact factor: 2.916

4.  Cell surface fucosylation does not affect development of colon tumors in mice with germline Smad3 mutation.

Authors:  Steven E Domino; David M Karnak; Elizabeth A Hurd
Journal:  Tumour Biol       Date:  2007-01-29

5.  Co-expression of CD173 (H2) and CD174 (Lewis Y) with CD44 suggests that fucosylated histo-blood group antigens are markers of breast cancer-initiating cells.

Authors:  Wei-Ming Lin; Uwe Karsten; Steffen Goletz; Ruo-Chuan Cheng; Yi Cao
Journal:  Virchows Arch       Date:  2010-03-19       Impact factor: 4.064

Review 6.  Glycosylation in cancer: mechanisms and clinical implications.

Authors:  Salomé S Pinho; Celso A Reis
Journal:  Nat Rev Cancer       Date:  2015-08-20       Impact factor: 60.716

Review 7.  Altered glycosylation in inflammatory bowel disease: a possible role in cancer development.

Authors:  B J Campbell; L G Yu; J M Rhodes
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

8.  The expression of human FUT1 in HT-29/M3 colon cancer cells instructs the glycosylation of MUC1 and MUC5AC apomucins.

Authors:  Anna López-Ferrer; Carme de Bolós
Journal:  Glycoconj J       Date:  2002-01       Impact factor: 2.916

9.  Expression and correlation of Lewis y antigen and TGF-β1 in ovarian epithelial carcinoma.

Authors:  Sheng-Tan Wang; Juan-Juan Liu; Chang-Zhi Wang; Bei Lin; Ying-Ying Hao; Yi-Fei Wang; Song Gao; Yue Qi; Shu-Lan Zhang; Masao Iwamori
Journal:  Oncol Rep       Date:  2011-12-01       Impact factor: 3.906

10.  Enhancement of metastatic ability by ectopic expression of ST6GalNAcI on a gastric cancer cell line in a mouse model.

Authors:  Hidenori Ozaki; Hideki Matsuzaki; Hidenobu Ando; Hiroyuki Kaji; Hayao Nakanishi; Yuzuru Ikehara; Hisashi Narimatsu
Journal:  Clin Exp Metastasis       Date:  2012-01-08       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.